A small observational study found that liraglutide, a GLP-1 receptor agonist typically used to treat diabetes and support weight loss, significantly reduced migraine frequency in adults with a BMI of 30 or higher—independent of weight change.
A large study has found that frequent nightmares in adults are linked to faster biological aging and a significantly higher risk of dying before age 75, highlighting a potential warning sign for long-term health risks.